Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

A 3-O-sulfated heparan sulfate binding peptide preferentially targets herpes simplex virus 2-infected cells.

Ali MM, Karasneh GA, Jarding MJ, Tiwari V, Shukla D.

J Virol. 2012 Jun;86(12):6434-43. doi: 10.1128/JVI.00433-12. Epub 2012 Apr 4.

2.

Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo.

Tiwari V, Liu J, Valyi-Nagy T, Shukla D.

J Biol Chem. 2011 Jul 15;286(28):25406-15. doi: 10.1074/jbc.M110.201103. Epub 2011 May 19.

3.

Synthetic analogues of bovine bactenecin dodecapeptide reduce herpes simplex virus type 2 infectivity in mice.

Shestakov A, Jenssen H, Hancock RE, Nordström I, Eriksson K.

Antiviral Res. 2013 Nov;100(2):455-9. doi: 10.1016/j.antiviral.2013.08.019. Epub 2013 Sep 5.

PMID:
24012999
4.

Reduction of herpes simplex virus type-2 replication in cell cultures and in rodent models with peptide-conjugated morpholino oligomers.

Eide K, Moerdyk-Schauwecker M, Stein DA, Bildfell R, Koelle DM, Jin L.

Antivir Ther. 2010;15(8):1141-9. doi: 10.3851/IMP1694.

PMID:
21149921
5.

Griffithsin and Carrageenan Combination To Target Herpes Simplex Virus 2 and Human Papillomavirus.

Levendosky K, Mizenina O, Martinelli E, Jean-Pierre N, Kizima L, Rodriguez A, Kleinbeck K, Bonnaire T, Robbiani M, Zydowsky TM, O'Keefe BR, Fernández-Romero JA.

Antimicrob Agents Chemother. 2015 Dec;59(12):7290-8. doi: 10.1128/AAC.01816-15. Epub 2015 Sep 14.

6.

Expanding the role of 3-O sulfated heparan sulfate in herpes simplex virus type-1 entry.

O'Donnell CD, Kovacs M, Akhtar J, Valyi-Nagy T, Shukla D.

Virology. 2010 Feb 20;397(2):389-98. doi: 10.1016/j.virol.2009.11.011. Epub 2009 Dec 11.

7.

Polyhydroxylated sulfated steroids derived from 5α-cholestanes as antiviral agents against herpes simplex virus.

Pujol CA, Sepúlveda CS, Richmond V, Maier MS, Damonte EB.

Arch Virol. 2016 Jul;161(7):1993-9. doi: 10.1007/s00705-016-2867-y. Epub 2016 Apr 21.

PMID:
27101075
8.

Prophylactic, therapeutic and neutralizing effects of zinc oxide tetrapod structures against herpes simplex virus type-2 infection.

Antoine TE, Mishra YK, Trigilio J, Tiwari V, Adelung R, Shukla D.

Antiviral Res. 2012 Dec;96(3):363-75. doi: 10.1016/j.antiviral.2012.09.020. Epub 2012 Oct 6.

9.

Mechanistic Studies of Viral Entry: An Overview of Dendrimer-Based Microbicides As Entry Inhibitors Against Both HIV and HSV-2 Overlapped Infections.

Sepúlveda-Crespo D, Ceña-Díez R, Jiménez JL, Ángeles Muñoz-Fernández M.

Med Res Rev. 2017 Jan;37(1):149-179. doi: 10.1002/med.21405. Epub 2016 Aug 12. Review.

PMID:
27518199
10.

In vivo anti-herpes simplex virus activity of a sulfated derivative of Agaricus brasiliensis mycelial polysaccharide.

Cardozo FT, Larsen IV, Carballo EV, Jose G, Stern RA, Brummel RC, Camelini CM, Rossi MJ, Simões CM, Brandt CR.

Antimicrob Agents Chemother. 2013 Jun;57(6):2541-9. doi: 10.1128/AAC.02250-12. Epub 2013 Mar 18.

12.

3-Hydroxyphthaloyl beta-lactoglobulin. IV Antiviral activity in the mouse model of genital herpesvirus infection.

Kokuba H, Aurelian L, Neurath AR.

Antivir Chem Chemother. 1998 Jul;9(4):353-7.

PMID:
9875414
13.

Comprehensive analysis of herpes simplex virus 1 (HSV-1) entry mediated by zebrafish 3-O-Sulfotransferase isoforms: implications for the development of a zebrafish model of HSV-1 infection.

Yakoub AM, Rawal N, Maus E, Baldwin J, Shukla D, Tiwari V.

J Virol. 2014 Nov;88(21):12915-22. doi: 10.1128/JVI.02071-14. Epub 2014 Aug 20.

14.
15.

Griffithsin protects mice from genital herpes by preventing cell-to-cell spread.

Nixon B, Stefanidou M, Mesquita PM, Fakioglu E, Segarra T, Rohan L, Halford W, Palmer KE, Herold BC.

J Virol. 2013 Jun;87(11):6257-69. doi: 10.1128/JVI.00012-13. Epub 2013 Mar 27.

16.

Topical application of polyethylenimine as a candidate for novel prophylactic therapeutics against genital herpes caused by herpes simplex virus.

Hayashi K, Onoue H, Sasaki K, Lee JB, Kumar PK, Gopinath SC, Maitani Y, Kai T, Hayashi T.

Arch Virol. 2014 Mar;159(3):425-35. doi: 10.1007/s00705-013-1829-x. Epub 2013 Sep 18.

PMID:
24046087
17.

Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b.

Rux AH, Lou H, Lambris JD, Friedman HM, Eisenberg RJ, Cohen GH.

Virology. 2002 Mar 15;294(2):324-32.

18.

In vitro and in vivo evaluations of sodium lauryl sulfate and dextran sulfate as microbicides against herpes simplex and human immunodeficiency viruses.

Piret J, Lamontagne J, Bestman-Smith J, Roy S, Gourde P, Désormeaux A, Omar RF, Juhász J, Bergeron MG.

J Clin Microbiol. 2000 Jan;38(1):110-9.

19.

An improved system for the evaluation of antiviral compounds against herpes simplex virus type 2.

Yin S, Li Y, Xia H, Zhao J, Zhang Z, Tang S, Kou Z, Chen J, Yu J, Fan Z, Li T.

J Virol Methods. 2013 May;189(2):317-20. doi: 10.1016/j.jviromet.2013.02.006. Epub 2013 Feb 27.

PMID:
23454799

Supplemental Content

Support Center